Loading cancer entity…
Loading cancer entity…
Clinical trials
181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (27)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02897297 | Myeloproliferative Neoplastic Diseases Observatory From Brest(OBENE) | unknown | — | 1,000 | University Hospital, BrestOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06251102 | Real-world Ruxolitinib Experience in PV(REVIEW) | unknown | — | 153 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 0 | May 9, 2024 |
| clinicaltrials |
| NCT05993065 | Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis. | unknown | — | 100 | Sohag UniversityOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05074550 | Safety Evaluation Study for Patients With Polycythemia Vera | unknown | Phase 1 | 6 | Perseus Proteomics Inc.INDUSTRY | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05566535 | Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice(QoL-PV-R) | unknown | — | 32 | Multinational Center for Quality of Life Research, RussiaOTHER | 0 | Oct 4, 2022 | clinicaltrials |
| NCT02809274 | Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features | unknown | — | 200 | Rambam Health Care CampusOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01284712 | Natural Killer Cells and Polycythemia Vera (Vaquez's Disease) | unknown | — | 27 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT01298934 | LBH589 (Panobinostat) for the Treatment of Myelofibrosis | unknown | Phase 1 / Phase 2 | 22 | Ronald HoffmanOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00668421 | CEP-701 (Lestaurtinib) in Myelofibrosis | unknown | Phase 1 / Phase 2 | 60 | Ronald HoffmanOTHER | 1 | Nov 26, 2014 | clinicaltrials |
| NCT01816022 | Myeloproliferative Neoplasms and Bone Structure | unknown | — | 125 | University of Southern DenmarkOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00866762 | A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 4 | Dec 12, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Aug 12, 2024source: clinicaltrials